NCT07147517 Preparedness Through Respiratory Virus Epidemiology and Community Engagement Status RECRUITING Phase N/A
NCT07007377 Can the Ergometric Test in Flu-like Syndrome Help in the Outcome Analysis of Unvaccinated Patients Status COMPLETED Phase N/A
NCT06626321 Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Replication Status COMPLETED Phase NA
NCT06385821 A Study to Prove Non-inferior Immunogenicity of Grippol Quadrivalent Compared to Grippol Plus Status COMPLETED Phase PHASE3
NCT06158659 Improved Immunology Outcomes Associated With Lactoferrin Fortified With HMO in Infant Formula Status COMPLETED Phase NA
NCT06057727 Behavioral Economics to Improve Flu Vaccination Using EHR Nudges Status COMPLETED Phase NA
NCT05473325 Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY) Status UNKNOWN Phase N/A
NCT05417997 Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients Status COMPLETED Phase PHASE3
NCT04515446 Quantification of Viral Load in the Upper Respiratory Tract in Patients Treated With Olsetamivir for Influenza Status ACTIVE_NOT_RECRUITING Phase NA
NCT03769012 Ability of Beta-glucan Supplementation to Augment Immune Function Status COMPLETED Phase NA
NCT03694808 FLUAD vs. FLUZONE HD Influenza Vaccine in Residents of Long Term Care Status COMPLETED Phase PHASE4
NCT03430089 Safety of a Single Dose or Two Doses of Shenzhen Quadrivalent Influenza Vaccine Status COMPLETED Phase PHASE1
NCT03344029 Immunogenicity and Safety of the Shenzhen Trivalent Inactivated Influenza Vaccine Versus a Trivalent Influenza Vaccine Comparator in Chinese Subjects 18 to 59 Years Status COMPLETED Phase PHASE4
NCT03308825 Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines Status COMPLETED Phase PHASE4
NCT03293979 Alere i FluA*B Biologic Test Relocated in Emergency Service for Flu Diagnosis Status COMPLETED Phase N/A
NCT03212716 Efficiency of Antagonist Drugs of the Cellular Transcriptomic Signature of Influenza A Virus Infection. Status TERMINATED Phase PHASE2
NCT03189537 Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections Status COMPLETED Phase PHASE3